Surface Logo New Version-color.png
Surface Oncology to Participate in the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
September 16, 2020 17:05 ET | Surface Oncology, Inc.
CAMBRIDGE, Mass., Sept. 16, 2020 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor...
Surface Logo New Version-color.png
Surface Oncology to Participate in the H.C. Wainwright Global Healthcare Conference
September 11, 2020 15:00 ET | Surface Oncology, Inc.
CAMBRIDGE, Mass., Sept. 11, 2020 (GLOBE NEWSWIRE) --  Surface Oncology (Nasdaq:SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor...
Surface Logo New Version-color.png
Surface Oncology Reports Financial Results and Corporate Highlights for Second Quarter 2020
August 11, 2020 06:30 ET | Surface Oncology, Inc.
CAMBRIDGE, Mass., Aug. 11, 2020 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor...
Surface Logo New Version-color.png
Surface Oncology to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference
August 05, 2020 11:59 ET | Surface Oncology, Inc.
CAMBRIDGE, Mass., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor...
Surface Logo New Version-color.png
Surface Oncology Announces Change to Location and Format of 2020 Annual Meeting of Stockholders
May 28, 2020 16:10 ET | Surface Oncology, Inc.
CAMBRIDGE, Mass., May 28, 2020 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor...
Surface Logo New Version-color.png
Surface Oncology to Present Preclinical Data for Multiple Product Programs at the American Association for Cancer Research Annual Meeting
May 15, 2020 07:30 ET | Surface Oncology, Inc.
CAMBRIDGE, Mass., May 15, 2020 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor...
Surface Logo New Version-color.png
Surface Oncology to Present at the American Society of Clinical Oncology Annual Meeting
May 14, 2020 07:30 ET | Surface Oncology, Inc.
CAMBRIDGE, Mass., May 14, 2020 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor...
Surface Logo New Version-color.png
Surface Oncology to Present at the UBS Virtual Global Healthcare Conference
May 13, 2020 08:00 ET | Surface Oncology, Inc.
CAMBRIDGE, Mass., May 13, 2020 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor...
Surface Logo New Version-color.png
Surface Oncology Reports Financial Results and Corporate Highlights for First Quarter 2020
May 12, 2020 06:20 ET | Surface Oncology, Inc.
CAMBRIDGE, Mass., May 12, 2020 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor...
Surface Logo New Version-color.png
Surface Oncology Announces First Patient Dosed in Clinical Trial of Immuno-Oncology Antibody SRF388
April 23, 2020 08:00 ET | Surface Oncology, Inc.
CAMBRIDGE, Mass., April 23, 2020 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor...